Before prescribing ONTRUZANT, please read the accompanying
Prescribing Information, including the Boxed Warning about cardiomyopathy,
infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
The Organon Access Program representatives can refer patients to the Organon Patient Assistance Program.
Patients who do not have insurance, or who cannot afford their prescribed Organon medicine even with prescription drug coverage, may be eligible for free product from the Organon Patient Assistance Program if they meet certain financial, medical, and/or insurance criteria.